Interest from startups in the BaseLaunch healthcare accelerator exceeds expectations
More than 100 projects from Switzerland and abroad competed for a place in the BaselArea.swiss accelerator program for healthcare startups.
By the closing date of June 30, the BaseLaunch startup accelerator received 112 applications. 77 percent of the projects were from Europe, with a total of 45 percent from Switzerland and 25 projects from the rest of the world. A third of applications involved therapeutics, 20 percent were concerned with diagnostics, and 18 percent with digital healthcare and healthcare services. Other projects focused on therapeutic platforms and services, medtech, and related fields. BaseLaunch offers startups infusions of funds, insight, infrastructure and industry access, and integrates them into one of the most dynamic biotech and healthcare ecosystems in Europe. The accelerator program initiated and operated by BaselArea.swiss aims to attract the next generation of successful healthcare companies by harnessing the unique position of the Basel region as a global life sciences hub. BaseLaunch is backed by healthcare partners Novartis Venture Fund, Johnson & Johnson Innovation and Pfizer. BaseLaunch also collaborates with digitalswitzerland as a healthcare vertical of Kickstart Accelerator.
Positive response to the call for applications
“The number of applicants far exceeded our expectations,” says Alethia de León, Managing Director of BaseLaunch. “We now have the task of selecting up to ten of the most promising projects for the first phase.” A selection committee made up of industry experts will be responsible for the selection process. Ventures accepted for the first phase of the program will receive grants of up to 10,000 Swiss francs beginning in September 2017. They will then have three months to develop their business ideas in close collaboration with the BaseLaunch team and a network of experienced entrepreneurs. Up to three startups will be selected from these companies for the second phase. They will each receive up to 250,000 Swiss francs and the opportunity to generate research data for one year in the laboratory of the Switzerland Innovation Park Basel Area and thereby achieve milestones in their business plan. Experts will also be available to advise and mentor during this time.
For Christof Klöpper, CEO of BaselArea.swiss, the large number of applications from abroad is a sure sign of the Basel region’s international reputation as a world-leading life sciences center. BaselArea.swiss has passed on to BaseLaunch all of its expertise in promoting innovation and investment. “We have many years of experience of networking innovators in the local area and supporting entrepreneurs by identifying suitable partners. BaseLaunch takes full advantage of this expertise, which is particularly valuable to participants from outside the region.”
The selected startups for the first phase will be announced in late summer.
For more information, please visit the BaseLaunch website.
Phase I: September 15 – December 7, 2017
Phase II: January 2 – December 21, 2018
Share this article
You might also be interested in
The biopharmaceutical company Kinarus has signed a capital commitment of up to 57 million Swiss francs with the investment group...Read More
The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...Read More